Zoetis (ZTS) Accounts Payables (2012 - 2026)
Zoetis (ZTS) reported Accounts Payables of $507.0 million for Q1 2026, up 20.71% year-over-year from $420.0 million in Q1 2025, and up 13.93% quarter-over-quarter from $445.0 million in Q4 2025.
Zoetis (ZTS) Accounts Payables (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Accounts Payables data on file, last reported at $507.0 million in Q1 2026.
- Accounts Payables for Q1 2026 came in at $507.0 million, up 20.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $507.0 million (up 20.71% YoY), and the FY2025 annual result was $445.0 million, up 2.77% from the prior year.
- Accounts Payables climbed to $507.0 million in Q1 2026 per ZTS's latest filing, from $445.0 million in the prior quarter.
- Over five years, Accounts Payables peaked at $508.0 million in Q2 2025 and troughed at $373.0 million in Q3 2022.
- A 5-year average of $426.4 million and a median of $420.0 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables decreased 9.48% in 2024, then advanced 20.95% in 2025.
- A 5-year view of Accounts Payables shows it stood at $405.0 million in 2022, then gained by 1.48% to $411.0 million in 2023, then climbed by 5.35% to $433.0 million in 2024, then grew by 2.77% to $445.0 million in 2025, then rose by 13.93% to $507.0 million in 2026.
- Business Quant data shows ZTS's Accounts Payables at $507.0 million in Q1 2026, $445.0 million in Q4 2025, and $410.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 45.88 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 306.87 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 10.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 507.00 Mn |
| Dec 31, 2025 | 445.00 Mn |
| Sep 30, 2025 | 410.00 Mn |
| Jun 30, 2025 | 508.00 Mn |
| Mar 31, 2025 | 420.00 Mn |
| Dec 31, 2024 | 433.00 Mn |
| Sep 30, 2024 | 404.00 Mn |
| Jun 30, 2024 | 420.00 Mn |
| Mar 31, 2024 | 405.00 Mn |
| Dec 31, 2023 | 411.00 Mn |
| Sep 30, 2023 | 388.00 Mn |
| Jun 30, 2023 | 464.00 Mn |
| Mar 31, 2023 | 424.00 Mn |
| Dec 31, 2022 | 405.00 Mn |
| Sep 30, 2022 | 373.00 Mn |
| Jun 30, 2022 | 430.00 Mn |
| Mar 31, 2022 | 402.00 Mn |
| Dec 31, 2021 | 436.00 Mn |
| Sep 30, 2021 | 387.00 Mn |
| Jun 30, 2021 | 369.00 Mn |